VPIM
LUCD icon

Vanguard Personalized Indexing Management’s Lucid Diagnostics LUCD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,536
Closed -$11.7K – 2030
2025
Q3 		$11.7K Buy
+11,536
New +$12.6K ﹤0.01% 1977

Other funds holding LUCD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Personalized Indexing Management's LUCD Position: Q4 2025 in Review

Vanguard Personalized Indexing Management sold out of Lucid Diagnostics (LUCD) in Q4 2025, closing a stake of 11,536 shares — an estimated $11.7K sold.

Vanguard Personalized Indexing Management first reported a position in LUCD in Q3 2025 and held it in 1 quarter. The position peaked at $11.7K in Q3 2025. 89 funds tracked by Wall St. Rank hold LUCD as of Q4 2025.

  • Vanguard Personalized Indexing Management reported no remaining Lucid Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 11,536 Lucid Diagnostics shares in Q4 2025, an estimated $11.7K.
  • Vanguard Personalized Indexing Management first reported a position in Lucid Diagnostics in Q3 2025 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Lucid Diagnostics position peaked at $11.7K in Q3 2025.
  • 89 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q4 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2025, filed 13 Feb 2026.